PALISADE BIO, INC. — Director's Dealing 2015

Sep 21, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Neuralstem, Inc. (CUR)
CIK: 0001357459
Period of Report: 2015-09-21

Reporting Person: JOHE KARL (Director, Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-09-21	Common Stock	S	25000	$1.5231	Disposed	1026304	Direct

Footnotes

F1: The transacton reported was effected pursuant to a 10b-5 trading plan.

F2: This transaction was executed in multiple trades at prices ranging from $1.49 to $1.59. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.